Today, I’m pleased to share an interview with Trish Brown, Vice President of Clinical Affairs at DNA Direct. Trish is a board-certified genetic counselor who has extensive experience in personalized medicine and has authored over 45 peer-reviewed posters, publications, and presentations.
DNA Direct is a genetic services company that recently announced their acquisition by Medco Health Solutions, Inc. to further their strategy to bring personalized medicine to the general public. DNA Direct provides genetic counseling support to physicians and patients and also offers direct-to-consumer genetic tests, paternity & family tests, and DNA Archive DNA storage that makes it possible to store DNA at room temperature.
In January, Trish presented at the Personalized Medicine World Conference in Silicon Valley. Her slides are also included below.
HUGO Matters: What do you think are the biggest challenges facing personalized medicine?
Trish: Lack of personalized medicine experts, and lack of access to available experts. DNA Direct has created information technology tools combined with a national call center of experts to provide education, decision support tools, and expert availability.
HUGO Matters: How do you think direct-to-consumer genetic testing and personalized medicine should be regulated?
Trish: DNA Direct is committed to providing responsible, reliable genetic information services and access to testing, when appropriate. We have developed guidelines and services to help ensure appropriate testing for all stakeholders across the healthcare continuum. We believe the industry should be focusing on the delivery of quality healthcare to improve outcomes.
Please leave any comments or questions for Trish in the comments!